Next-Generation Sequencing (NGS) and Arrays to Profile Transcriptomic and Epigenomic Regulation in Cell Biology

Next-Generation Sequencing (NGS) and Arrays to Profile Transcriptomic and Epigenomic Regulation in Cell Biology

Fraz Syed, PhD, Marketing Manager, Britt Flaherty, PhD, Product Manager, Kevin Taylor, PhD, Sr. Manger, Market Development, Complex Disease , Illumina, Inc.
Topic: Human Genetics & Genetic Disease

Join us for a live webinar and gain a better understanding of genomic techniques used to profile the transcriptome and epigenome in complex, multifactorial disease. NGS and array platforms can allow for greater flexibility when studying gene mutations, gene expression and epigenetic regulation. Learn how NGS and arrays are advancing the study of complex disease, and in investigating various factors that can affect disease phenotype.



There are no related events.